New test for acetaminophen poisoning

liver411

New test for acetaminophen poisoning
Medical Studies/Trials
Published: Tuesday, 5-Sep-2006

A new test for acetaminophen poisoning is effective with children as well as
adults, according to a study published this month by researchers at the
University of Arkansas for Medical Sciences (UAMS) and the Arkansas
Children's Hospital Research Institute (ACHRI).
The study, led by Laura James, M.D., an associate professor of pediatrics in
the UAMS College of Medicine and an ACHRI researcher, was published in the
September issue of Pediatrics, the journal of the American Academy of
Pediatrics.

Acetaminophen is the one of the most widely used drugs for treatment of pain
and fever in the United States. Though safe at recommended doses, the drug
can cause liver damage with excessive doses. Acetaminophen overdose is the
most common cause of acute liver failure in adults in the United States.

"As a diagnostic tool, this test shows promise as a sensitive test for
acetaminophen poisoning when previously used tests proved inadequate," said
James, who also is an adjunct professor in the UAMS Department of
Pharmacology and Toxicology. "Ultimately, making the correct diagnosis can
lead to better recognition, improved education and hopefully prevent future
acetaminophen overdoses."

Currently the diagnosis of acetaminophen-related liver injury is based on an
elevated level of the drug in the blood and a patient history of using
excessive doses of the drug. Acetaminophen is only present in the
bloodstream for about 24 hours following a large overdose.

James' work centers around a protein compound, called cysteine adducts, that
forms with toxic doses of acetaminophen. Previous study has shown the
protein marker to be present in the blood for up to nine days, signaling
possible acetaminophen poisoning after the drug has already left the blood,
James said.

In the newest research, the test cited possible acetaminophen overdose in a
number of cases where the cause of liver damage had not been determined. The
test for the protein marker also confirmed the diagnosis in nine out of 10
blood samples (90 percent) from children with liver failure attributed to an
acetaminophen overdose.

In the study documented in Pediatrics, the team that included James and Jack
A. Hinson, Ph.D., a professor in the UAMS Department of Pharmacology and
Toxicology, tested blood samples from children with liver damage already
diagnosed as caused by acetaminophen; patients with liver damage from other
causes; and patients with liver damage from undetermined causes.

The test identified potential acetaminophen toxicity in eight of 64 samples
(12.5 percent), a statistically significant percentage, from patients with
liver damage of undetermined cause. A history of acetaminophen exposure was
present in five of those eight patients. Liver biopsy or autopsy was
performed in four of those eight cases, and researchers described the liver
damage as characteristic of injury from acetaminophen toxicity.

The study followed work in which James and Hinson participated on adult
blood samples. Those results, showing the test was effective in detecting
adult cases of acetaminophen overdose, were published in the March 2005
issue of the journal Gastroenterology.

James said the next step in the research is continued study of blood samples
to further refine the protein adducts test. Her research is funded by a
grant from the National Institutes of Health through the National Institute
of Diabetes and Digestive and Kidney Diseases.